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wing sarcoma is the second most common pediatric sarcoma 
round cell tumour also occurs in soft tissue, predominantly at older 
age, however in general the majority of patients are under the age of 
million, and responds well to chemotherapy combined with surgery and/
at the time of diagnosis, and their outlook is unfavourable with event-
options for these patients, Ewing sarcoma is studied in a variety of 
origin of Ewing sarcoma has not been determined as of yet, generating 
transgenic models to accurately recapitulate the disease has proven to 
Danio rerio) has steadily been gaining 
been made for various types of cancer, and xeno- and allotransplantation 
of cancer cells has been performed in both adult and embryonic 
especially attractive for several reasons: large numbers of transparent 
embryos can be obtained from one pair of adults, they are transparent 
and thus highly suitable for non-invasive live imaging of various cancer-
innate and adaptive immune systems are segregated in time, preventing 
 
The two following chapters are written to provide background knowledge 
general introduction on Ewing sarcoma, with an overview on what is 
currently known about the genetics and molecular processes affected 
the chapter lies on automation, and how state-of-the-art technologies 
combinatory treatment targeting both p53 regulation and transcriptional 
1
13
activation via deacetylation, and is associated with metastatic Ewing 
activation of p53 by lack of SIRT1 suppression leads to cell death in vitro 
In chapter 6, the previously established Ewing sarcoma xenograft model 
We investigate how behavior of Ewing sarcoma cells robotically 
Ewing sarcoma engraftments in the 2-day-old xenograft model, and 
By placing the EWSR1-ERG driver gene under an UAS promoter, it is 
1

Introduction on Ewing sarcoma
16
Etissue sarcoma affecting children and young adults, and is most 1,2 First 
diffuse endothelioma of bone” 3, 
this tumour is composed of small round cells expressing CD99 on the 
membrane, and is characterised by an EWSR1-ETS translocation, most 
commonly EWSR1-FLI1 1 
Tumour localisation and site of origin






2 Circa 25% of patients 
present with metastasis at the time of diagnosis 5-7, most commonly in 
2 It is currently unknown 
biomarkers, it has been ascribed to endothelial, reticuloendothelial, 
8-10 Evidence 
points to the latter two as the most likely candidates, and in the following 
 A neural-crest derived cell has long been hypothesised to 
monophosphate, EWS cells may undergo neural differentiation and 
express neural-associated enzymes like enolase 2 and choline 
11
12,13 Occasionally, tumours have 
14 EWSR1-FLI1 or EWSR1-
ETV1 can drive neural differentiation in cells of various origins, not only 
15,16 This suggests that not the cell of origin 
 Various studies showed that introduction of EWSR1-ETS was 
only tolerated by immortalised cells, or cells lacking p19ARF, p16INK4A, or 
17-19 Such deletions are not found in the majority of EWS tumours20, 
pointing to the existence of a non-mutated primary cell type that can 
tolerate expression of  EWSR1-ETS 21 Murine 
expressing EWSR1-FLI1 adopted histological and genetic hallmarks 
21
EWSR1-ETS 
22,23 Inversely, when EWSR1-ETS knockdown was 
performed in EWS, cells took on features of MSCs 24,25
that MSCs can derive from the neural crest 26-28 is an interesting point 
in the debate on the origin of EWS, and may reconcile the two lines of 
Genetic alterations
translocation, merging EWSR1 FLI1 
1 The fusion of EWSR1 with 
ERG, , 29,30 
Both FLI1 and ERG are members of the erythroblast transformation-
which contains a transcriptional activation domain31,32, and these DNA 
2
18
In addition to the more common EWSR1-FLI1 and EWSR1-ERG 
translocation events, other fusions between members of the TET family 
EWSR1 and FUS) and members of the ETS 
‘Ewing-like’ tumour do bear other chromosomal translocations, such as 
the CIC-DUX4 or BCOR-CCNB3 34,35An overview of these more rare 
 Besides the characteristic EWSR1-ETS translocation, other 
alterations such as a gain of chromosomes 8, 12, 2, 5 or 9 have been 
48-53 An unbalanced 




Mutation or downregulation of CDNK2A is reported in 10 to 30% of 
20,58-61 Encoding P16INK4A, loss of CDNK2A has been shown 
20,59,62  Other mutations, such as in 
TP53 have also been shown to lead to a poor prognosis, although 
63 Inactivating 
mutations in STAG2 are reported in 9 to 21% of EWS cases64,65, appear 
to be mutually exclusive with CDKN2A, while co-associating with TP53 
66 This latter combination of mutations leads to a poor outlook 





Current treatment regime and clinical outcome
Overall survival rates of EWS patients with localised disease have starkly 
improved since the introduction of systemic therapy to the treatment 
2 Patients with localised disease currently have an overall 
67
5-
7,68,69 Patients who solely have lung-metastases seem to fare somewhat 
7,70
Standard protocol for treatment of Ewing sarcoma upon diagnosis is 
71,72 
In Europe, the chemotherapeutic regime consists of multiple cycles of 
72,73
 When patients have recurrent disease, the 5 year post-recurrence 
74-
76
Further treatment depends on the site of recurrence and prior methods 
77




remains high and more targeted therapeutic strategies are desirable to 
Immunoprecipitation and yeast two-hybrid studies show that EWSR1-
FLI1 protein interacts with a multitude of other proteins involved in 
transactivating potency of EWSR1-FLI1, leading to an increase of 
81,82 Moreover, some resultant alternative 
transcriptional products regulate transcription themselves, like ID2, GLI1 
81,83-85 This leads to a higher amount of aberrant transcription, 
which complicates determining which expressional changes are critical 
for oncogenesis, versus those whose differential expression plays no 
have been implicated to play a key role in the pathogenesis of EWS and 
 One of these candidate targets for treatment is the IGF-pathway: 
86 The activation 
of the IGF-pathway leads to MAPK and PI3K-AKT-mTOR signalling, 
87 Inhibitors interfering with 
IGF1R signalling were shown to be effective both in vitro an in vivo88-90, 
antibodies against IGF1R91, indicating that alternative signalling routes 
et al. show that sensitivity to IGF1R kinase inhibitor 
could be induced in highly drug-resistant cell lines by targeting MST1R 
2
21
Macrophage Stimulating 1 Receptor, a cMET related tyrosine kinase, 
92 OSI-906, a dual inhibitor targeting 
IR in addition to IGF1R is also being tested, and may provide a better 
87 Besides IGF1R, other tyrosine kinases receptors such as 
PDGFR93-95, KIT93,95-97 and FGFR198,99, are also found to be upregulated 
100,101 
cell cycle regulation, EWSR1-FLI1 downregulates p21WAF1 expression, 
possibly by impairing the histone deacetylation activity of transcriptional 
102 Loss of p21WAF1
60  Low expression of another cell cycle 
inhibitor, p57KIP 103 Induced expression or 
depletion of EWSR1-FLI1 caused respectively a decrease or increase 
of p57KIP 103,104
upregulated by EWSR1-FLI1 presence, and plays a role in modulation of 
various signalling pathways crucial for EWS survival, as well as affecting 
 Mechanisms of intrinsic chemotherapy resistance are also worth 
considering, as circa 23% of the patients show little to no response to 
105 EWS tumours have been described to express 
ABCB1 ABCC1 MRP1 105 Both genes 
belong to the ATP-Binding Cassete transporter family, and their products 
at mRNA level, ABCC1 is expressed in 80% of samples, independent 
of prior chemochemical treatment, while ABCB1 is expressed in only 
106 Another study, investigating ABCB1 expression via 
immunohistochemistry, observed P-glycoprotein expression in 51 to 
107 They also observed that half the tumours negative for 
Besides ABC transporters, GSTM4, 
108,109
 Most studies on potential novel treatment regimens are initially 
conducted in vitro, then tested in murine models, before being considered 
essential step before moving on the patient trials, the high cost and long 
duration of these experiments limits the rate at which compounds can be 
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Abstract
large numbers at low costs,  embryos develop externally and in 
limited space, making them highly suitable for high-throughput 
processes and their manipulations within the larvae is possible due to 
their transparency during development, and a multitude of available 
 In high-throughput studies, handling large amounts of embryos 
overview is given of the developments in the automation of various 
focus will lie on various tools designed for cancer cell implantation, 
Introduction
widespread, and different models have been generated for a variety 
1-3 
Langenau et al. 
in which expression of murine mMyc in lymphoid cells drove the onset 
4 Other transgenic cancer models followed5-15, such as 
activated human BRAFV600E leading to invasive melanoma formation 
7, or an embryonic model for rhabdomyosarcoma 
induced by activated human RAS 9 In addition to transgenic models, 
xenotransplantation models were developed, and tumours cells from a 
range of cancer types and species were shown to be able to proliferate, 
16-24  In these 
models, cells can be implanted  at different stages, from blastula and 
sites, like the yolk, Duct of Cuvier25, perivitelline space17 26 
In addition to xenotransplatation with cancer cells of human or murine 
27,28  
 Many papers highlight the opportunity provided by these animals 
3
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embryos were used in a screen identifying small molecules affecting 
development29, and immersion of embryos in compounds is now an 
30,31 With the development of various 
intensive, monotonous task, and automation of different steps of the 
process would both increase speed, precision and reproducibility of 
 Automated systems for injection, compound treatment, imaging 
application will be for engraftment models, or transgenic models where 
overview of the advances in automation regarding each stage of cancer 
Automated microinjection systems
are performed in embryos up to 16 cell stage, and currently available 
At these early stages, the yolk cell is the largest cell in the embryo, 
injections have to be performed at high rate, to ensure proper uptake by 
et al., embryos were 
32 Using image 
recognition software, different structures in the embryos could be 
recognized, and the site of injection was determined based on this 
et al., was primarily designed for injection 
of south-African clawed frog Xenopus laevis oocytes, but utility for 
33
in commercially available 96-well microplates with conical wells, and the 
3
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a plunger-driven injection system, which allowed automated cleaning 
 In 2011 Carvalho et al
that, in addition to being suitable for gene disruption injection in early-
stage embryos, could also be applied to inject pathogens such as 
Mycobacterium marinum into the yolk of embryos of up to 1024-cell 
34 In this injection system, embryos were positioned in an agarose 
grid with a honeycomb pattern of hemispherical wells, and the site of 
experiment in mind, with a variety in number of wells for small or large 
scale experiments, or multiple small grids of wells to distinguish groups 
calibrated on-screen, and easily adapted during the run of the experiment, 
embryos could be infected with M. marinum bacteria at a rate of 2000 
cell stage has been described in this system, as well as the possibility 
to perform gene knockdown by injection of antibodies or siRNAs, and 
35 For additional details, 
refer to publications by Veneman et al. for an overview of the setup36, 
and its application in Staphylococcus epidermidis 37
Therefore the applicability of this automated injection system for cancer 
types could be successfully injected into the yolk of embryos between 
35 Osteosarcoma 
system operated largely in the same manner as described by Carvalho 
et al.  Due to the 
larger size of tumour cells when compared to bacteria, needles with a 
tumour cells tended to sediment in the needle more rapidly, and clump 
implantation rates were 80 to 90%, and showcases the suitability of the 
parameters may have to be performed for each cancer cell line to be 
3
37
Schematic representation of the injection platform described by Carvalho 
et al 34 Embryos are positioned into an agarose-cast grid of hemispherical 
beneath the agarose plate is used in calibrating the parameters of injection 
 Example 
of agarose cast grid in different forms: the dark grey areas show a grid-pattern 
when multiple injection parameters are used, or different compounds are 
3
38
of the embryonic developmental program on the cancer cells injected at 
38
 Thus far, the described automated injection systems are primarily 
as tolerating larger volumes, another key difference of older stages is 
that it is also possible to engraft in compartments other than the yolk 
Duct of Cuvier25 or the heart cavity, and enables following extravasation 
17 The 
PVS was also used as an implantation site in a recent publication by 
macrophages in the tumour microenvironment on intravasation and 
39
Glioblastoma multiforme cells was investigated by performing injections 
26 In infection studies, injection of 
bacteria in the hindbrain have been performed to study macrophage 
recruitment40-42, and injection of bacteria into the otic vesicle induce 
43  Similar injections could 
types of injections is the inter-individual variations in body shape of 
high-precision maneuvers concerning minute structures, the slightest 
Furthermore, with the loss of radial symmetry during embryonic 
development, positioning of the embryos is also a more time-consuming 
 A system for performing these kinds of injections was recently 
44 This system positions 
orientated in either a dorsal orientation by several pulses of mechanical 
high-speed camera and image-recognition software, the position of each 
and posterior-anterior axis serve as reference coordinates to determine 
achieved a success rate between 84% and 93% of implanting 4 dpf 
larvae in different orientations in a variety of organs such as forebrain, 
3
39
 Another aspect to consider when aiming to perform high-
response, loss of individual embryos during the experiment, and the 
intention to use multiple concentrations per compound means that tens 
of thousands of reproducibly injected embryos are needed to screen a 
presented in a paper by Addato et al., which describes development of a 
45 In 
the breeding vessel, females and males are separated until the desired 
spawning time, when the researcher removes the barrier separating the 
 
volumes of compound to be taken up from the water in which they are 
are commercially available, having been previously developed for cell 
is possible in plates with an optical bottom, or sideview plates in which 
46
the dispensing of embryos to well plates, and are described in the 
 Pfriem et al.
dispensing embryos from a Petri dish to a well plate that works by 
unhatched), and analyzing this image to determine coordinates of each 
47 
a pipette tip, whilst a built-in sensor detects if the embryos are indeed 
3
40
incorporated, the simple design may be cheaper than other available 
This modular design allows the addition or removal of parts, dependent 
 A similar system is described by Mandrell et al., where a 4-axis 
Selective Compliant Assembly Robot A
5-6 hpf embryos from a Petridish based on coordinates obtained from a 
48
semi-transparent embryos are taken up with the pipette mounted on the 
49 This ‘Complex Object Parametric Analyzer and 
Sorter’ takes up embryos from a reservoir in the system, and leads them 
By gating the parameters, the system can deposit the embryos in well 
plates of various formats, or discard them if they do not comply with 
be particularly useful in combination with an automated injection system, 
described by Graf et al.50
setup makes use of light barriers to control opening and closing of 




  An in-depth explanation of the rationale of design and 
papers by Khoshmanesh et al.51 and Akagi et al.52, from the group of Dr 
inlet of the LOC device, hydrodynamic forces cause the docking and 
immobilization of embryos at these traps, whilst allowing remaining 
can be completely perfused through the system via the inlet and outlet 
internal volume of the described  LOC device in these papers was under 
are made with microscopic glass slides, in-device microscopy can be 
 As a proof of concept, Akagi et al. perform an on-chip 
52 After loading transgenic embryos 
with either vehicle control, or Tivozanib, a VEGFR inhibitor effectively 
follow-up papers, the group of Wlodkovic describe a further developed 
53,54  The new design includes a small suction 
 
via combined gravitational sedimentation and low-pressure suction 
forces
et al 35,55
makes this an interesting system is that actuator-regulated monolithic 
valves are present in the channels leading into and out of each 
the ability to monitor effects of drug treatment on the cancer-associated 




et al 54 Embryos are loaded at the inlet through the main channel, along which 
and low-pressure suction forces, embryos are immobilized in the embryo 
was integrated in a platform with an electronic interface regulating automated 
et al 55  In this device, consisting of 24 wells 
feeding into the wells have actuator-controlled monolithic valves, which open 
 Schematic representation 
et al 57 In this device, embryos are 
immobilized via combined gravitational sedimentation and low-pressure 
3
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and that of Akagi et al. 52 show that it is possible to investigate cancer-
related processes in these LOC devices, with only very small amounts 
 In the device presented by Wielhouwer et al.56, embryos 
through of medium is attained via the presence of multiple in- and out-
making it possible to maintain stable temperature gradients on a small 
et al 57
employs combined gravitational and suction forces to trap the embryos, 
and
positioned on the side of each embryo trap, enabling the possibility to 
shaped as a conventional 96-well plate, it is compatible with automated 
 A limiting feature of the above described LOC devices, is that 
they are unsuitable for embryos older than 72 hpf, as at this time the 
developed by Bischel et al. 58 
In the Entrapment By Restriction A
are guided through small channels via surface-tension driven passive 
they will be positioned laying on their side, or dorsal/ventral side facing 
location where the larvae  will be trapped, for an easy and rapid method 
imaging 3-5 dpf larvae without the need for agarose embedding, which 
is time consuming and can impair embryonic development due to 





embryos are still small relative to one well of a 96-well plate, the use of 
with an array of agarose molds, to restrict the space the embryo will 
61
Prisms placed adjacent to the wells allow imaging the embryos from the 
stage, complete 96-well plates of consistently oriented embryos can be 
integrated detection software to locate and recognize the orientation of 
63 
Vertebrate Automated Screening 
T 63,64, similarly takes up anesthetized 
embryos from a suspension cup or plate and leads them through tubing 
eventually stopped so that the embryo is positioned in a glass capillary 
has a similar refractive index to it, making microscopy with high numeric 
In this system, optic manipulations and even laser microsurgery can 
be performed63
larvae engrafted with MDA-MB-157 breast cancer cells, imaged from 
individual embryo passes  the beams of various lasers, excitation levels 
3
45
 Schematic representation of the Vertebrate 
Automated Screening T
reverted, until the embryo is positioned in a glass capillary mounted beneath 
embryo 
MDA-MB-157, 
magenta)  Example of images taken in the 
6 dpi PC3-Pro4, magenta) are 
3
46
called ARQiv utomated R in vivo) was presented 
by Walker et al.65
demonstrated to allow detection of inter-individual variation of expression 
process is rapid and non-invasive, alterations of expression levels can 
Image analysis
In development and toxicology research, alterations in phenotype of 
analysis software packages designed for recognizing various structures 
61, 66-69 
the interference of non-relevant signal, is to use recognition software 
70 Pixel-counting is a rapid analysis tool, but provides 
no information on the migration capabilities of cancer cells within the 
by Ghotra et al 60
individual tumour cell cluster, the size and migration distance away from 
 In another program called zebIAT, developed by Annila et al., a 




useful information on the seeding amount and preference of cells to 
home to certain organs or structures and warrants further development 
 Schematic of embryos 
In the correctly re-
The coordinates of each tumour cell cluster is plotted in a dot plot, where the 
3
48
et al 72 does not make use of images of whole embryos containing 
ex vivo. For this 
purpose, engrafted embryos are dissociated,  the cells pelleted and then 
in silico 
macro, and was shown to allow detecting of difference in proliferation 
information on migration or establishment of metastases, the sensitivity 
of this approach is advantageous for when there are only limited 
numbers of embryos per group, which is likely the case in large-scale 
Concluding remarks
embryos are produced in large numbers, and the external development 
multiple well-characterized cancer models have been established 









growth factor-beta signalling controls human breast cancer metastasis in 
3
51
Puppa A, Bresolin S, Battilana G, Indraccolo S, Te Kronnie G, Argenton F, 
setup to study Staphylococcus epidermidis and Mycobacterium marinum 
3
52
Real-time visualization of mycobacterium-macrophage interactions leading to 
702

















ranslocations involving ETS-transcription factors, most commonly 
leading to the EWSR1-FLI1 fusion protein, are the hallmark of 
progression and tumour burden in vivo, applicable for screening of single 
gene TP53 is commonly found to be wild-type, thus providing an attractive 
TP53
and TC32) and TP53
investigate the potentiating effect of p53 reactivation by Nutlin-3 on 
sarcoma tumour cell burden irrespective of TP53
in an additive inhibition of TP53-wild-type Ewing sarcoma cell burden, 
whilst not affecting TP53
inhibition of proliferation and migration by combinatorial treatment was 
in vivo 
compounds together additively induced apoptosis of tumour cells in 
vivo 
p53 pathway in combination with complementary targeted therapy by 
EWSR1-FLI1 transcriptional activity disruption as a valuable strategy 
Introduction
1 Transformation is believed to be caused 
by a chromosomal translocation fusing the EWSR1 gene to a member 
of the ETS transcription factor family of genes, resulting in a highly 
2 The two most common gene fusions 
are EWSR1-FLI1 EWSR1-ERG 
3,4 Around 25% of patients have metastasis present at the time 
5 Currently, these patients have a 2-year event-free survival 
6
of the transcriptional activity of EWSR1-ETS oncogene in combination 
7 To test this hypothesis, 
two potential drugs operating via a different mode of action were 
used in this study: Nutlin-38




Individually, these compounds are known to modulate EWS tumour 
tumour growth in mice xenografts9, and reactivation of the p53 pathway 
by Nutlin-3 induced an apoptotic response of EWS cell lines in vitro.10 
Danio rerio) are increasingly used as a model 
11 ex 
utero development, temporal separation between innate and adaptive 
12 There is 




4 weeks post-fertilisation16, allowing circumvention of cell graft-host 
compounds from water, which is advantageous when screening for 
17-21
vasculature or neutrophil granulocytes22,23, allows live imaging of cancer 
development and interaction with the microenvironment in vivo within 1 
applicable for real-time in vivo monitoring of tumour progression at single 
cell level, by recording induction of angiogenesis, EWS proliferation 
and migration, as well as tumour cell interaction with the host immune 
 In this chapter, we show both in culture and in vivo that p53 
Both compounds caused tumour cell apoptosis in vivo via distinct 
EWSR1-ETS transcriptional deregulation as an attractive therapeutic 
Cell culture




ABTL, Albino, Casper, , and tp53M214K 
nimal welfare regulations 
experiments were approved by the animal care committee of the Faculty 
24
24-well plate in a volume of 1mL Instant Ocean egg water supplemented 
Embryos were imaged in glass-bottom 96-wells plates using a NIKON3 
25
Proliferation assay in cell culture
For measurement of relative EWS cell survival of each treatment, 3000 
or 5000 cells/well were seeded in triplicate in full medium in a 96-wells 
relative growth was measured using a WST-1-based colorimetric assay 
4
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synergy studies, effects were calculated as ‘affected fraction’ of treated 
26 Dose–effect 
Western blotting
27 Gels were 
loaded with 10-15 
 
28 The following antibodies were used:  CD99-O13 
TUNEL staining was performed using ApopTag Peroxidase in situ 
apoptosis was performed by counting TUNEL-positive versus TUNEL-
negative cells, for >4 embryos per condition, and noted in the text as 
mean percentage apoptotic cells ± 
A one-way ANOVA test with a Dunnet’s post-test was utilized to determine 
the in vivo
 can be used as a host 




suitable model organism for Ewing Sarcoma progression, a panel of 
EWS cell lines was implanted in the yolk of two days post-fertilisation 
 
 Cell lines derived from metastatic and primary tumours were 
selected for different translocation types, and status of the p53 pathway 
34,35 
Implanted cell lines differed in potential to induce angiogenesis, ranging 
response by implanted cells and exclude response to injection-induced 
capable of forming tumour-cell outgrowths, primarily in proximity of the 
 All tested cell lines proliferate and migrate within the embryo and 
most EWS cells were showed the ability to induce angiogenic response 
 A) Cells stably 
B) Schematic 
C) 2 dpf  embryo with green vasculature22, injected 
D) Regular development 
of the subintestinal vein complex of an uninjected 3 dpf  
E) Angiogenic sprouting of vessels from the subintestinal vein complex induced 
by the implanted EWS cells in F) Interaction 
) Proliferation, outgrowth and migration to head of ABTL 
K ) Migration to 





as the percentage of embryos which showed cells migrating away from the 
 A) EWS cells 
embryo, 
C) 
D) Confocal overview 
image of embryo with EWS cells spreading to the head, muscles 
E) TG(mpx:GFP)i114 
Further analysis on engrafted larvae was performed to get an insight into 
Immunohistochemistry demonstrated that migratory cells were positive 
2), thus retaining EWS properties in vivo









that migration of EWS in embryos resembles metastatic behaviour in 
 To exclude false-positive results for migration due to cell debris 
and macrophages at this stage of development), cells were implanted 
23 Neutrophils and 
played a role in migration, leukocytes were detected by whole-mount 
that some, but not all EWS cells in the body of the larvae were taken 
previous experiments, indicating that macrophages are responsible for 
7, providing an 
Nutlin-3 to have an adverse effect on the malignant potential of EWS 
cells37
allow the escape of non-respondent cells, which can be reduced by 
transcriptional activity by blocking the interaction between RNA helicase 
A and EWS-FLI1 protein9
 We tested the sensitivity of p53-wild-type EW7, CADO-ES1 
and TC32 and p53-deletion SK-N-MC cell lines in culture for various 
 Nutlin-3 reduced the growth of EW7 in a dose-dependent manner 





 A) WST-1 assay for measuring relative survival of EW7 
 B) WST-1 assay for measuring 
 C) 






cell lines with a differential p53 expression have dissimilar responses to 
12,38 To determine if our xenotransplantation model was suitable 
 As pathways concerned with cancer can be involved in larval 
development, we initially performed toxicity tests on mock-injected 
in vivo
applied to tp53M214K 
39,40 This protein plays 
41 
After implantation with EW7 and SK-N-MC cells in larvae, treatment with 
information on the amount, size and migration of tumour cell foci per 
 in vivo  A) 
Quantitative analysis25 of embryos implanted with SK-N-MC cells, treated with 
outline of the  embryo 
site of implantation was determined per object and represented in scatter dot 
B) Tumour burden of EWS cells in embryos, 6 dpi, normalized against 
 
C








The combination of compounds had an additive effect on this decrease 
by Nutlin-3, and minimal additive effects were observed for double 
 Migration from the site of implantation was determined for all 
 Our in vivo 
7), as well as previously described research on single treatments with 
9,37 Additionally, we managed to rapidly 
investigate the synergistic effects that these two compounds had on 
EWS, showing an additive effect of combined treatment on the reduction 
of tumour burden in vivo. 
 in 
vivo and in culture 
MC cells implanted in larvae, we performed whole-mount TUNEL staining 
response was increased more effectively in EW7 cells than SK-N-MC 
Treatment with both compounds simultaneously showed that the majority 
 
revealed that in EW7, both compounds increased p53 protein levels, 
4
71
 The data obtained both in vivo 
induces apoptosis in EWS cells in a p53-independent manner, whilst 
increased apoptosis of tumour cells by engaging these mechanistically 
Discussion 
In this study, we investigated the additive effect of p53 reactivation 
on disruption of EWSR1-FLI1 transcriptional activity as a therapeutic 
bone and soft-tissue tumour for which currently, when presented with 
TP53 7, and up-regulation provides 
to lose viability upon forced wild-type p53 expression42  
TP53 as well as CDKN2A/CDKN2B (p16), another important regulator 
of G1/S transition, are described to be correlated with an unfavourable 
43-45
model to assess reactivation of p53 by Nutlin-3 as a treatment approach 
could induce angiogenesis, migrate and proliferate within a week after 
model allows rapid medium-to-high-throughput screening of preclinical 
compounds in multiple subjects and can be a useful complement to 
account: the compounds need to be water-soluble and taken up by the 
rapidly dividing and migrating, which might pose a problem, as these are 
design, we took into consideration that pathways that are important 
in cancer development can also be involved organ developmental 
3 dpf, when the larvae have already undergone some of the most crucial 
embryos were chosen as high as possible to maximise the effect on 
The use of tp53M214K  mutant larvae, which fail to undergo apoptosis in 
46, determined 
 To inhibit EWS progression via inactivation of two essential 
tumourigenic mechanisms and investigate their therapeutic value in vivo, 
4
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Nutlin-3 was used to stabilise p53 by blocking its interaction with MDM2, 
the reduction of tumour cell burden by these compounds in vivo. Tumour 
4-279, while Nutlin-3 reduced tumour growth only of the p53-wild-type 
of apoptosis in vivo was observed, suggesting a less straightforward 
response than found in culture 
additive effect on reduction of tumour burden of p53-wild-type cells by 
 In this model, treatments were applied relatively soon after 
implantation, to achieve the longest possible treatment time before 
additional immune-systems become activated and engraftments may be 
time of diagnosis, any promising treatment found needs to be tested 
 Several Phase I clinical trials with RO5045337, an analogue of 
a follow-up trial is active for various cancer types, amongst which patients 
NCT01462175)47, and could perform a similar synergistic function as 
 A) Whole-
B) The relative survival of EW7 cells and SK-N-MC cells treated with 
 C) Western blot for EW7 and SK-






enantiomer has enhanced therapeutic potency compared to a mixture 
48
effects and brings this compound one step further to the initiation of 
found that simultaneous induction of the p53 pathway and disruption 
of EWS-FLI1 transcriptional activity to have an additive effect on the 
reduction of EWS malignancy in vivo
strategies with reactivation of the p53 pathway in this tumour type may 
be a promising therapeutic strategy for the subset of EWS patients 
harbouring wild-type p53, and should be investigated in further detail in 
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suppression involving modulation of the deacetylase SIRT1, providing 
a rationale for the use of SIRT1 inhibitors to treat cancers where this 
validated in Ewing sarcoma cells, B-cell tumors, and human keratinocytes 
Notably, the SIRT1/2 inhibitor Tenovin-6 killed Ewing sarcoma cells in 
vitro and prohibited tumor growth and spread in an established xenograft 
tissue specimens, we found that high SIRT1 expression was associated 
suggest a mechanistic rationale for the use of SIRT1 inhibitors being 
Introduction
proteolytic cleavage steps catalyzed by TNF -converting enzyme and 
the presenilin-
1 Only few CSL targets are known, most prominently the 
suppresses differentiation, whereas in others, it exerts an opposite 
2 
activation by mutation occurs in many cancers including T-cell leukemia 
and a variety of solid tumors including breast, colorectal, ovarian, and 
activation has a tumor-suppressive effect, including keratinocytes, 
tumors of the prostate, liver, skin, lung, gastrointestinal stromal tumors, a 
5
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3 Currently, the 
 Ewing sarcoma pathogenesis is driven by the chimeric ETS 
oncogene EWS-FLI1
transcription factor with both activating and repressive gene regulatory 
4 We have previously reported that EWS-FLI1 represses 
JAG1 5 We found that 
silencing of EWS-FLI1 results in activation of tumor cell autonomous 
which was paralleled by activation of the tumor suppressor TP53 and 
3 
in Ewing sarcoma cell lines, but the mechanism of TP53 activation 
 We here demonstrate that knockdown of EWS-FLI1 and induction 
6 
7
deacetylase preventing TP53 acetylation downstream of suppressed 
 Sirtuins are an evolutionarily highly conserved protein family 
protection from neurodegenerative diseases, organismal longevity, and 
8 Of the seven members of this family 
in man, SIRT1, 3, 6, and 7 localize mainly to the nucleus, whereas SIRT2 
SIRT1, 2, 3, and 5 catalyze NAD+-dependent deacetylation of targets, 
the repression of euchromatic gene regulation as part of a corepressor 
others, this complex binds to CSL and represses genes regulated by 
9 In addition, SIRT1 can 
modulate NICD activity by deacetylation as demonstrated in endothelial 
1 Gene regulation by SIRT1 is also affected by deacetylation of 
with TP53 and deacetylates Lys382, thus reducing the transcriptional 
7,11 Knockdown of SIRT1 allows for TP53 acetylation, 




in vitro and 
prohibits growth and migration of tumor cells in vivo
Cell lines, transfections, and drug treatments
are routinely subjected to mycoplasma and SMRV testing in regular 
puromycin-selected cells were harvested, washed, and subjected 
used in the study have previously been published and are listed in 
Proliferation and viability assays
Cell viability was assessed using the colorimetric MTT metabolic activity 
4 cells per well) were cultured 
in 96-well plates at 37°C and exposed to varying concentrations of Tnv-
Seventy two hours after treatment, 20 
50
) values were calculated by using 
antibody binding, blots were incubated for 1 hour with either horseradish 
5
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peroxidase–coupled secondary antibody for chemiluminescent 
detection with Super Signal West Pico chemiluminescent substrate 
TP53 was precipitated with either CM1 or DO1 antibodies and probed 
For promoter activity analysis, TC252 Ewing sarcoma cells were plated 
at an initial concentration of 104
performed using Renilla
3 
levels of the genes assessed were calculated by the 2 Ct)
13 containing 280 
containing primary tumor samples with complete clinical follow-up from 
sarcoma tumor and corresponding metastasis tissues were obtained 
and interpretation of staining results were performed as previously 




were loaded as a single-cell suspension in 2% polyvinylpyrrolidone-40 
six embryos were placed per well of a 24-well plate, in a volume of 1 
mL Instant Ocean eggwater supplemented with either DMSO or Tnv-6, 
were imaged in glass-bottom 96-well plates using a NIKON3 confocal 
15 
activates TP53 in Ewing sarcoma upon silencing of EWS-FLI1, but 
3 Because TP53 stability 
wide gene expression changes were compared with the EWS-FLI1 
5
91
component of protein phosphatase 2A dephosphorylating TP53 at 
various residues including Thr55, Ser37, and Ser4622-24, and SIRT1, 
a type III deacetylase known to target histone and non-histone proteins 
We observed a marked upregulation of SIRT1 RNA expression in 59 
primary Ewing sarcoma samples as compared with 89 normal tissues 
the regulation of the TP53 pathway16, we therefore focused our further 
in wild-type TP53
line 697, the B-cell lymphoma cell line Nalm-6, and primary human 
line U2OS by siRNA increased SIRT1 accompanied by TP53 modulation 
signaling, ectopic NICD1 expression also induced SIRT1 downregulation 
we performed EWS-FLI1 knockdown in the absence and presence of 
26,27





acetylation of TP53 and activation of TP53 target genes such as CDKN1A 
ectopic expression of increasing amounts of SIRT1 in the presence of 
in Ewing sarcoma is involved in functional impairment of TP53 activity, 
 We next tested for the impact of SIRT1 modulation on cell fate of 
that SIRT1 expression may serve as a promising pharmacologic target 
29 As shown in 
50
 values between 
50
 values were found in cell lines with 








assays were conducted in TC252 cells upon cotransfection of the indicated 





consistent with the induction of acetylated TP53 and of CDKN1A as 
Tnv-6–induced cell death on TP53 was best demonstrated by rescue of 
cell viability without any change in SIRT1 expression levels if TP53 was 
knocked down before Tnv-6 treatment in wild-type TP53 TC252 cells 
not on SIRT2, as SIRT2 knockdown failed to rescue TC252 cell death 
Ewing sarcoma cells are highly sensitive to Tnv-6 treatment and that the 
level of sensitivity depends on the presence or absence of intact TP53 
Because inhibition of SIRT1 was able to kill Ewing sarcoma cell 
lines, we tested Tnv-6 for tumor-inhibitory activity in an established 
30 Two cell lines with 
high and low SIRT1 expression and distinct Tnv-6 in vitro sensitivity 
TP53 cell line TC252 and the TP53-mutant cell 
SIRT1 in TC252 cells by shSIRT1 results in TP53 K382 acetylation and TP53 




yolk sac of 
mol/L Tnv-6 for 4 days, 
and growth and spread of tumor cells through the embryo body were 
results for all embryos injected in three independent replica experiments 
in a scatter plot that visualizes the distance and direction of migration for 
P
P
interferes with Ewing sarcoma growth and migration in vivo
To validate SIRT1 expression in primary tumors, we screened 392 
samples gave informative results, of which 272 samples and 26 samples 
displayed moderate and strong nuclear SIRT1 staining, respectively 
for primary tumors from patients who presented with metastases at 
P
for the informative primary tumors from patients with metastatic disease 




sarcoma metastases, we tested an independent series of 14 paired 
cases 15–18), we found lung metastases to score positive in 88% and 
5
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Knockdown or pharmacologic inhibition of SIRT1 but not of SIRT2 
kills Ewing sarcoma cells in vitro
was counted 4 days after transfection with the indicated constructs and is 
and determination of IC
50
induces acetylated TP53 and CDKN1A expression in TC252 cells but not in 
TP53 shRNA and treated with 8 
Trypan blue-excluding cells were counted after 72 hours of Tnv-6 treatment, 
and mean results and SDs from one representative of two experiments, 
modulation by shP53 and SIRT1 expression were monitored by immunoblot 
cell numbers were determined relative to the number of cells before start of 
as high as observed on the TMAs for the primary tumors of patients 
SIRT1 positivity, we independently tested a third previously published 
cohort of 43 patients with Ewing sarcoma with complete clinical follow-
probability for the 12 SIRT1-positive patients was 25% as compared 
5
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TP53, high SIRT1 expressing 
TC252, or TP53 mutant low SIRT1 A673 cell lines were implanted into the yolk 
sac of the indicated numbers of 
 embryo and estimate 
The distance of migration away from the site of implantation was determined 
per object and cumulative results for all embryos from three independent 
x, y
of TC252 and A673 cells in embryos after three days of drug treatment, 4 days 
5
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independent experiments with a total of 214 and 126 embryos for TC252 and 
t
SIRT1 expression in primary human Ewing sarcoma samples 
the distribution of SIRT1 positivity levels among informative primary tumor 
with nuclear SIRT1 staining are considered positive and indicated in red and 
5
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prospective studies to validate the potential prognostic importance of 
SIRT1 in Ewing sarcoma, our combined data strongly imply SIRT1 as 
a candidate therapeutic target in patients with Ewing sarcoma with 
Discussion
not only in Ewing sarcoma but also in other malignancies and tissues for 
B-cell lymphoma cell lines and primary human keratinocytes, leading to 
previously been described to be involved in the epigenetic transcriptional 
SIRT1 forms a corepressor complex with LSD1, CoREST1, and CtBP1, 
here) and also LSD131 to be consistently expressed in Ewing sarcoma, 
5, this mechanism 
factor CSL, this corepressor complex is replaced by mastermind-like 
9 In addition, NICD stability 
has been reported to be prolonged by acetylation, which is modulated 
1
32
 It also adds a putative feedback mechanism of potential prognostic 
stability and activity but also TP53 has been demonstrated to suppress 
SIRT1 expression through transcriptional repression via binding to a 
TP53 response element in the SIRT1 promoter33 and posttranscriptional 
Interestingly, hsa-mir-34a and two other SIRT1 regulatory microRNAs, 
hsa-mir-132 and hsa-mir-93, were recently described components of 
35 





it is intriguing to speculate that the TP53/hsa-mir-34a/SIRT1 gene 
the yolk sac, the site of tumor cell injection, is only poorly vascularized 
–positive endothelial cells in 
the tail but also to the head region of the embryos, Tnv-6 likely inhibited 
active tumor cell migration, consistent with the documented role of SIRT1 
36 This migration inhibitory effect could not 
be studied in vitro because of the strong cytotoxic effect of Tnv-6 and of 
induction upon perturbation of SIRT1 expression or activity was mainly 
due to activation of TP53 and could be rescued upon knockdown of 
in wild-type TP53 cell lines, which are representative of more than 90% of 
37
to Tnv-6 treatment, albeit at much higher doses, which is likely due to 
the broad transcriptional and epigenetic roles of SIRT1 in genome-wide 
29 Although it cannot 
be excluded that part of the in vitro cytotoxic activity of Tnv-6 may be 
due to a non-SIRT1/non-TP53–related activity such as induction of 
autophagy as previously observed in CLL38, it did not play a role in the 
ES cohorts reproducibly indicated increased SIRT1 expression in 
primary tumors in localized and metastatic disease were comparable, 
still with a tendency toward higher numbers of positively staining tumor 
and focal SIRT1 expression might have led to an underestimation of 
SIRT1-positive cases in the primary tumors of metastatic patients on 
that not only metastatic patients but also patients with localized but 
 While there is already evidence that Sirtuin activators are clinically 
well tolerated, early clinical trials with SIRT1 inhibitors have only recently 
5
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4, SIRT1 suppresses TP53 activation by NAD+
5, TP53, when active, suppresses SIRT1 by direct binding to its promoter33 
of NICD1
9 
additional mechanisms are known to activate or repress SIRT1, including 
39,41, microRNAs40, kinases42-47, 
and sumoylation48  that integrate microenvironmental signals with SIRT1 
to the SIRT1 promoter49
5
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patients with Ewing sarcoma and sensitivity of SIRT1-positive tumor 
cell lines to SIRT1 inhibition in vitro and in vivo may therefore open an 
 
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1  




Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates  DNA-
subunit, B56gamma, mediates DNA damage-induced dephosphorylation of  p53 
DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to  facilitate 
5
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Discovery, in vivo activity, and mechanism of action of a small-molecule p53  
Ewing sarcoma inhibition by disruption of EWSR1- FLI1  transcriptional 
drug target in chondrosarcoma, Ewing’s sarcoma, osteosarcoma,  and 




dependent protein kinase kinase beta phosphorylation of Sirtuin 1 in  endothelium is 
sumoylation regulates its deacetylase activity and cellular response to  genotoxic 
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and  
mir- 145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback  








wing sarcoma tumours occurs predominantly in children and young 
We propose automated robotic implantation of Ewing sarcoma cells into 
 In a previous study we have shown engraftment of Ewing 
in vivo
embryos in compounds with anti-cancer activity, reduction of proliferation 
and migration of Ewing sarcoma cells was observed in vivo
 To further expand upon this model and make it available for high-
throughput screenings, we studied how manual and robotic engraftment 
compared to the previously described manual injections to the yolk of 
cells engrafted at blastula stage were able to proliferate, but migrated 
 Automated robotic implantation was optimised, and using this 
in vivo
cells in vivo was mostly comparable to in vitro results, though there were 
 
Introduction 
1,2 Metastases at the time of diagnosis, 
indicative of a poor prognostic outlook, are found in approximately 
2 For these patients it is essential that newly 
6
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and external development of the embryos make them highly suitable for 
real-time in vivo visualization of processes involved in cancer and have 
led to transgenic3-5 and xenotransplantation models6,7 for various cancer 
8-10 Simultaneously, their low maintenance 
cost, high fecundity and ability to take up small molecule compounds 
from water, prompted their use in high-throughput chemical screens for 
a multitude of purposes, ranging from development11 and teratogenicity12 
13 14 For melanoma, a presently on-going 
15,16 
based on the analysis of deregulated processes by checking abnormal 
17,18 Signalling pathways involved 
in oncogenesis are often also involved in embryonic development, so 
19 
Manual injection, while relatively fast, is a labour-intensive method for 
In 2006, Wang et al.
20 Designed to perform injections for 
system injects embryos within a few hours after proliferation, at a rate 
was developed which could perform such injections at a rate of 2000 
21 Moreover, this system could also be employed 
to inject other substances, for example Mycobacterium marinum 
bearing human tumour cells may be obtained for extensive compound 
22 In this study, we demonstrate the utility of this automated 
 Previously, we have described a xenotransplantation model 
10 These cells induced angiogenesis in the larvae and could 
could severely impede these processes, showing the applicability of this 
adapted this model to a high-throughput method, by engrafting EWS 
after manual engraftment in the yolk of blastula stage embryos versus 
robotic injection of EWS cells, to generate large numbers of embryos 
treated with different compounds to show the potential of this method for 
6
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 Compounds chosen to validate the model were vincristine, and 
23 It is a member of 
the vinca alkaloid class of drugs, preventing microtubule formation by 
24 The second compound 
4-279 blocks the interaction between EWSR1-ETS, the oncogenic 
25 This causes 
deregulation of transcription and has been shown to be effective in the 
10,25
279 molecule bears a chiral centre, giving rise to two enantiomers, which 
Barber-Rotenberg et al. 26 They found 
In this study, we show that the robotic engraftment of EWS in blastula-




ABTL wildtype and 
to local animal welfare regulations and maintained according to standard 
tanks with spacers, where one male and one female are placed on either 




a 1% agarose grid with a honeycomb pattern of 512 hemi-speherical 
a 1% agarose grid with 1mm wide grooves, in which eggs were placed 
dishes, and water was removed to the point that the embryos were 
embryos were rinsed and maintained with Instant Ocean egg water with 
At 1 dpf, six embryos were placed per well of a 24-well plate, in a volume 
of 1mL Instant Ocean eggwater supplemented with chemical compounds 
other day for toxicity tests, or once at 4 dpf for treatment of injected 
were imaged in glass-bottom 96-wells plates using a NIKON3 confocal 
27 
Proliferation assay in cell culture
For measurement of relative EWS cell survival of each treatment, 3000 
cells/well in a volume of 100 µL were seeded in triplicate in full medium in 
times, relative growth was measured using a WST-1-based colorimetric 
6
114
A one-way ANOVA test with a Dunnet’s post-test, or unpaired t-test was 
utilized to determine the in vivo
Statistical analyses were performed using GraphPad Prism software V4 
blastula and larval xenograft models
EWS, looking at proliferation and migration of EWS cells, as well as 
for high-throughput applications such as anti-cancer drug screenings, 
it is desirable that embryos engrafted with cancer cells are generated 
scoring was done of the percentage of embryos that showed 3 or more 
subset of embryos from 4 dpi onwards, and migration increased during 
 Next, we looked at the kinetics of proliferation of EWS cells in the 
the time of cell implantation: 2 dpf embryos are more robust, and up to 
more fragile, and implanting more than 250 cells per embryos will cause 
cell burden half-way through the course of the experiment at 3 dpi, which 
6
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site of implantation in the yolk of a 2-day-old larva is indicated with a magenta 
 Schematic drawing of cell implantation in the blastula xenograft 
Percentage of embryos with 3 or more cells migrating away from the site of 
 Percentage 
of embryos with 3 or more cells migrating away from the site of implantation, 




In order to see if the cell burden reduction observed at 8 dpi in the 
blastula model was caused by increased cell death compared to the 
2 dpf xenograft model, apoptotic cells were visualised using a whole-
Left 
panel: representative image of whole-mount TUNEL staining of EWS cells 
embryos 
Left panel: 
representative image of whole-mount TUNEL staining of EWS cells in the 
embryos 
Whole-mount 
immunohistochemical staining of blastula stage-engrafted embryos with CD99, 
Whole-mount immunohistochemical staining 
of blastula stage-engrafted embryos with L-Plastin, showing EWS cells 
6
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In addition to observed cell burden reduction in the blastula, EWS 
amount of migration is reprogramming of EWS cells due to factors within 
28 
We performed an immunohistochemical stain with the EWS marker 
 Cells engrafted in the blastula xenograft model may be taken 
Leukocytes were present near the engrafted EWS cells, and interacted 
robotic injection
While the blastula xenograft model did not result in many embryos with 
migrating cells in this time course, the data it gives on tumour-cell burden 
is valuable for investigation of anti-proliferative effects of compounds on 
investigations on how to automate blastula injections, which resulted in 
 Figure 3A shows a schematic representation of the robotic 
injector developed for the injection of Mycobacterium marinum 21 
Embryos between 2 and 4 hpf are placed on a 1% agarose grid of 512 
allows for easy placement of the embryos at regular intervals using a 
regulates injections parameters such as injection time, pressure, depth 
which are loaded with cell suspension, and inject the embryo by moving 
 Right after implantation, embryos with cells implanted in the yolk 
Embryos are incorrectly implanted when cells are present in the body 
6
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 The rate of successful implantation is highly dependent on 
is partially delayed by using high-viscosity 14% PVP to re-suspend cells, 
tips which can easily be broken open with tweezers to provide an opening 
Schematic drawing of the automated robotic set-up for cell implantation in 
Example image 
 Example 
image of a correctly implanted embryo, 24 hours after implantation, showing 
 Example image of an incorrectly 
implanted embryo, 24 hours after implantation, showing EWS cells in the body 
 Example image of an embryo, 24 hours after implantation, 
showing cells EWS cells in the yolk of the embryo, as well as a faint glow 
Right and middle: closed needles pulled using different programmes of a 
6
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these needles clogging was a common problem, leading to interruptions 
reduced clogging, but there was more variation in upon breaking open 
be reduced by opening the needles by grinding the tips down, rather 
were achieved with custom-made Qvotek needles with a 20 µm opening 
After optimisation, a successful-injection percentage of 88% could be 
in vitro 
for screening large compound libraries, we performed a test with three 
the clinic to treat patients with EWS, often in combination with ifosfamide, 
23,29
EWS growth in vivo
10,25 Separation of the racemic mixture into an active 
in vivo experiments, 
caused a relative reduction of survival of 50% after 24 hours of treatment 
was observed between concentrations of 3 µM or 30 µM at this time-
in vivo
Before applying compounds to the treatment of embryos engrafted with 
toxicity tests on non-injected wild-type embryos can be found in Figure 
6
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Final concentrations to be used for treatment of the engrafted embryos 
were chosen to allow >80% survival of embryos in the case of Vincristine 
After implantation with A673, EW7 or TC32 cells in blastula-stage 
27 
was performed on confocal images, providing information on the amount 
the cumulative area of tumour foci) in treated groups was plotted relative 
  Vincristine treatment of EWS cells in the xenograft transplantation 
in vitro  
WST-1 colourimetric assay for measuring 
relative survival of A673, EW7 and TC32 




Toxicity test of 
Vincristine, 
 on ABTL embryos 
were checked twice daily, and 
deceased embryos were removed 
Compounds were refreshed every 
6
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 Treatment of engrafted embryos with the two enantiomers of 
burden in any of the groups, as expected based in previous research 
and in vitro
previously shown that in the 2-day-old engraftment model a racemic 
in 
 
cells in vivo   
Tumour burden of EWS cells in embryos, treated with 
Differences between means were obtained by an unpaired t-test, or one-way 




 These in vivo results largely recapitulated results previously 
on different EWS cells in vivo
Discussion
 
In this study, we investigated the possibility to develop an automated 
robotic injection system for engrafting Ewing sarcoma cells into blastula-
poor, and novel therapeutic strategies are needed to improve event-free 
response of tumour cell in vitro to certain treatment regimens is not 
always recapitulated in an in vivo
as the microenvironment in which the tumour cells reside will also 
have thorough screening in in vivo settings before drugs are considered 
shown to be effective against EWS in vitro in initial screens can be 
selected further for their ability to reduce cancer cell malignancy in vivo 
in vivo 
 While we focus on automated implantation here, more aspects 
can be considered to fully adapt this system for high-throughput drug 
screening purposes, manual sorting of embryos correctly implanted 
embryos, transferring these to well plates and applying compounds 
of analyzing, sorting and dispensing live multicellular organisms based 
analysis is done in a semi-automated way, which is possible to do with 
Automated Screening Technology) BioImager platform developed by 
This platform can take up embryos from a well plate, send them to a 
6
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addition to rapidly capturing images of the embryos, may also eject 
imaged embryos to different well plates, which provides the option to 
 Screening at multiple time-points will provide more data on the 
This may be of interest not only for the blastula-stage xenograft model, 
information on the migration capabilities of the EWS cells, for which 
compounds discerned in initial large-scale screening in the blastula 
model can be augmented with data on effects on migration from the 2 
primarily children and young adults, it is imperative to have a complete 
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wing sarcoma, a highly malignant bone and soft-tissue tumour, is 
characterized by the presence of a translocation between EWSR1 
and a member of the ETS family of genes, most commonly FLI1 or 
ERG
no transgenic mouse models have been established that can accurately 
unknown, confounding which promoter is suitable to drive the expression 
of EWSR1-ETS
model for Ewing sarcoma, where expression of GFP-tagged EWSR1-
that neuronal cells are more permissive of EWSR1-ERG expression than 
EWSR1-ERG,
embryos by the human oncogene compare to a previously described 
TG(14xUAS:GFP-
of EWSR1-ERG expression in different background tissues and it 
is a promising tool to study processes involved in Ewing sarcoma 
Keywords: 
Introduction
primarily in children and young adults, is characterized by a reciprocal 
translocation between EWSR1 1 
2 
Additionally, it interacts with other transcription factors, causing further 
2-5
fusion gene EWSR1-FLI1 6 Another 10% of cases has an EWSR1-ERG 
7,8 
alterations of TP53 and CDKN2A/CDKN2B (p16), have been described 
9-12
diagnosis13 14 The 5-year 
15 Finding more effective 
7
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treatments for these patients is needed, and in addition to established in 
vitro and xenotransplantation models, a transgenic animal model would 
be desirable for studying the mechanism of action of the chimeric protein 
in vivo, 
 Despite knowing the genetic aberration responsible for driving 
oncogenesis of EWS, thus far no transgenic murine models have been 
animal model for EWS is its elusive cell of origin, and toxicity of EWSR1-
EWSR1-
FLI1 in cells in vitro has caused apoptosis or senescence in most 
normal cells, and many of such models depend on additional cellular 
16-18 To date, 
only mesenchymal stem cells have been found to tolerate EWSR1-ETS 
19,20 While this knowledge points 
to express the oncogene, all attempts at establishing transgenic mouse 
in vitro toxicity, 
expression of exogenous EWSR1-FLI1 in one murine model resulted in 
21 In another mouse model there was development of 
22 
23 A stable 
solid tumours with histologic features of small round blue cell tumours 
in a p53-/- 24
nerve sheet tumours, and tumours histologically similar to EWS are 
10% of EWS patients25, so further optimization is needed to mimic the 
 To circumvent the problem of embryonic lethality upon expression 
of EWSR1-FLI1, we used the Gal4/UAS binary system to drive expression 
26 In this system, the gene of interest is 
placed under control of a UAS promoter, which becomes activated only 
in the presence of Gal4 element, expressed in transgenic lines under 
EWSR1-ETS genes under 
control of the UAS promoter and introducing this construct into the 
germline, there will be no transcription of the gene until the transgenic 
the gene of interest directly 
research, considering the exact cell of origin for this cancer is, as of yet, 
 In this study, we show the transforming capabilities of human 
7
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EWSR1-FLI1 and EWSR1-ERG 
embryonic stages, and describe the establishment of TG(UAS:GFP-
, 
driver lines, we explore possible tissue tolerances to EWSR1-ERG 
lost after 24 hours, but expression in the neurons of embryos was 




line was generated in an enhancer trap 
screen described by Scott et al.27 The 
hzm1 line was generated in an enhancer trap screen described by Distel 
et al 28 The line was previously described 
by Scheer et al.29 The was newly 
approved by the animal care committee of the Leiden University Medical 
5’-TCACAATTGGCAGAGCTGGTTTAGTGAACCG TC-‘3 forward primer 
introduced an MfeI restriction site at the 5’ end of the GFP-EWSR1-
ETS ORF, whilst the 5’-TCAGCGGCCGCTCTAGATCCGGTGGATCA 
resultant amplicon was cloned into the 14xUAS E1b Tol2 transposon-
Generation of 
Tol2 transposase mRNA was generated by using a linearized pCS2FA-
7
133





forward primer 5’-GTCTCAGCCTCACTTTGAGC-3’ and reverse primer 
The transgenic  and TG(14xUAS:GFP-
lines were crossed, and their offspring were heatshocked 
Embryos of x Et(E1b:Gal4-
RNA isolation was performed by homogenizing 15 embryos per sample, 
RNA samples of 3 dpf  x Et(E1b:Gal4-




 The complete dataset has been deposited in NCBI’s 
Gene Expression Omnibus and are accessible through GEO Series 
uploaded on Database for Annotation, Visualization and Integrated 
31,32 
Complementary DNA synthesis from RNA samples of 3 dpf 
 x  and 
wildtype siblings was achieved by combining 1 g of RNA with 4 µL of 
were incubated at 25°C for 5 min, 42°C for 30 min, and 85°C for 5 
the following cycling parameters: 95°C for 3 min, followed by 40 cycles 
of denaturation at 95°C for 15 and annealing/extension at 60°C for 45 
s, followed by 1min at 95°C and melting curve generation by 10 s at 
-actin housekeeping gene, 
and results were analysed using the 
leads to oncogenic transformation





At 6 hpf, GFP-positive cells could be found among the cell mass for 
GFP-EWSR1-ERG injected 
ERG underwent division, whilst others showed membrane blebbing, 
transgenic line, 
efforts to generate an UAS:GFP-EWSR1-FLI1 were not succesful. Further 
experiments were carried out with progeny of the TG(14xUAS:GFP-
 To determine which Gal4 driver line was suitable to investigate 
, a line in which Gal4 expression is driven by 
hsp70 Hsp70 is normally expressed 
in the lens of developing embryos, but will be expressed throughout the 
6hpf resulted in expression of GFP- EWS-ERG in the yolk and part of the 
 Crossing UAS:EWS-ERG with 
hzm1 
expressed GFP-EWS-ERG primarily in cells along the notochord of 






Schematic of CMV:GFP-EWSR1-ETS constructs injected in to 1- to 8-cell 
Mosaic expression of GFP-EWSR1-ERG in a 6 
 Mosaic expression of GFP-EWSR1-ERG in the head of a 30 
 Mosaic expression of GFP-EWSR1-ERG in the tail of a 30 hpf 





ABTL wildtype embryos were injected in the cell at 1-cell-stage with a mixture 
Injected embryos were raised to adulthood, and a PCR reaction on DNA 
the GFP-EWS-ERG construct, which we named 
7
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ERG and Kaede is localised to the neurons of the embryo, as early 
GFP-EWS-ERG were severely underdeveloped, with expression found 
embryos showing this phenotype, embryos expressing the brighter, photo-
convertible Kaede were removed, as not to complicate interpretation of 
EWS-ERG expressing embryos maintained expression at least until 
After observing the various phenotypes obtained by crossing UAS:EWS-
embryo RNA samples from S1101T:Gal4/UAS:EWS-ERG and control 
a bioinformatic software package developed within our research group 
www.genetiles.com 44
between samples of the same group was calculated using Pearson 





UAS:EWS-ERG crossed with Kita:Gal4 
 UAS:EWS-ERG crossed with S1101T:Gal4 resulted in expression in 
7
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et al.24, there was 
cathepsin L.1 annexin 
A5a, defensin beta-like 1, 3-hydroxy-3-methylglutaryl-CoA synthase 
This low number of commonly regulated 
genes could be due to comparing an embryonic whole-body expression 
our model to the embryonic transgenic model described in the same 
analysis, we aimed to look further into this and other biological processes 
 For 
31,32
of terms such as ‘Developmental process’, ‘P53 signalling pathway’ and 
the embryos can explain the extremely low p-value for enrichment of 
addition to these expected enrichments, introduction of EWS-ERG also 
affects biologic processes and pathways linked to cancer, such as the 
MAPK signalling pathway that plays an important role in orchestrating 
transgenic S1101T:Gal4/UAS:EWS-ERG embryos compared to other 
in 
vitro
34 From the 
such as metabolism, signalling and transcriptional and translational 
genes is gstm, encoding a glutathione-S-transferase enzyme which is 





of genes differentially expressed in S1101T:Gal4xUAS:EWS-ERG at 3 dpf, 
core regulated gene-set as determined by comparison of human and murine 




has been shown to increase sensitivity of EWS cell lines to conventional 
36 ) and 
nmi
EWS cell growth in vitro 37 Among the 
lox
a tumour suppressor when ectopically re-expressed in EWS cell lines, 
38 
 
In Figure 4C and 4c’, within regular muscle tissue, clusters of cells were 
observed with round nuclei and little cytoplasm, bearing a resemblance 
Discussion
in vivo research on these tumours, 
for future usage of this model for preclinical screens in searching for a 
model has been unsuccessful, due to the toxicity of EWSR1-FLI1, the 
can produce small blue round cell tumours expressing EWSR1-FLI1 
24
23
We circumvented problems of embryonic lethality by placing the 
expression of the EWSR1-ERG and EWSR1-FLI1 oncogene under a 
UAS promoter, which is silent in the absence of Gal4, allowing transgenic 
EWSR1-FLI1 was 
EWSR1-ERG
promoters, we could study the effect of GFP-tagged EWSR1-ERG 
the toxic effects of EWSR1-ERG expression as most embryos lost 
7
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different locations at different stages of development may improve 
promotor is prone to methylation, which can cause transcriptional 
39 Using a promoter with fewer UAS copies may diminish this 
Embryos resulting of a cross between the  
considering various lines of evidence point to neural crest as the currently 
unknown tissue of origin for EWS40-43, a tissue which also gives rise to 
More detailed characterization of the embryos neuronally expressing 
EWSR1-ERG revealed an overlap of genes regulated in the embryonic 
various other transcriptional studies investigating the role of EWSR1-
34 Several of the genes found this way have been shown to 
It would be interesting to see how the phenotype of the transgenic 
can be done with chemical inhibitors added to the water of the embryos, 
down of gstm, encoding glutathione-S-transferase, should increase 
) or re-expression of lysyl oxidase 
lox
on offspring of 
explanation as to why there was a relatively low overlap between the 
a set of genes regulated by both EWSR1-FLI1 and EWSR1-ERG, and 
different translocation types could point to key genes essential for EWS 
ERG provided by the use of the Gal4/UAS binary system allows for 
adaptation of the model as knowledge about the tissue of origin of Ewing 
shows overlap with other studies previously done, validating its use for 
7
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further investigation of these genetic pathways in the progression of this 
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wing sarcoma, a pediatric sarcoma affecting bone and soft tissue, 
is characterized by a translocation event which merges between 
patients an EWSR1-FLI1 fusion gene is present, another 10% of patients 
effects that these EWSR1-ETS fusions can have on a transcriptomic 
level, much less studies have been dedicated to investigate the 
where expression of human EWSR1-ERG is driven by the conditional 
Gal4 under neuronal promoter generates offspring with EWSR1-ERG 
Massive expression of EWSR1-ERG transformed cells  leads to 
ERG expression have no discernable tissues or organs, and show a mix 
of GFP-expressing and non-expressing cells in no obvious organized 
In this study, we have performed comparative LC-MS/MS on the wild 
type embryos and embryos expressing a driver of Ewing sarcoma at 3 
dpf, to investigate the effect of the human EWSR1-ERG oncogene on 
example, we found that Notch proteins  levels were lower in transgenic 
in vivo
Notch reporter and is in line with previously described transcriptional 
Introduction
EWSR1-FLI1 and EWSR1-ERG are the two most commonly occurring 
1-4 The cell or tissue of origin of these tumours is not yet 
to clusters of cells expressing the gene that are undergoing proliferation 
UAS expression system, we observed variances in permissiveness of 
8
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showed that various cancer-associated pathways were affected in these 
of various EWS models5
 While there have been numerous studies published on the effect 
of EWSR1-FLI1 knockdown or ectopic expression in cell lines on an 
of EWSR1-FLI1 on a protein level has been investigated by looking at 
the interactome6, or by knockdown of EWSR1-FLI1 and investigating 
7 Other studies 
described changes in protein expression after interference with genes of 
8,9
 LS-MS/MS with spectral counting is a label-free method to 
It offers a cheaper alternative to stable-isotope labeling, which is 
10 
 This study shows the effects of expression of human EWSR1-
embryos expressing EWSR1-ERG have altered protein expression 
Many proteins were enriched in the gene ontology term ‘oncogenesis’, 
in vivo, using Notch signaling 
8
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was newly generated in the Leiden 
approved by the animal care committee of the Leiden University Medical 
s1999t line was generated in an enhancer trap screen described by 
Scott et a 11 The ia7 notch reporter 
line was generated by Schiavone et al.12, and was used to create the 
, ia7 line. 
oC for 30 minutes, 
centrifuged at 16,000g at 4 oC  for 15 min and the supernatant was 
containing 1% SDS, 50 U/mL benzonase, and 2 mM MgCl
2
, followed 
 Circa 40 µg of protein was loaded on a 1 mm 10-well 4-12% 
lanes were cut into 48 identical slices fractions using a custom-made 
twice for 30 minutes at room temperature with 30% acetonitrile in 25 mM 
iodoacetamide in 25 mM ABC with incubation at room temperature in 
8
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For each analysis, 10 
Dublin, CA) coupled parallel and connected to a split less NanoLC-Ultra 
species in the mass range of 300-1300 m/z were selected for tandem 
mass spectrometry and actively excluded for one minute after having 
13 using 
were searched with X!Tandem14  using the k-score against a Danio 
rerio
15  The data of both searches were combined 
16
MD)17,18 19
IDs were uploaded to DAVID, and GO term enrichment was checked, 




Tricaine at 2 dpf after embedding in 1% low melting point agarose 
In order to asses changes on a protein level in embryos expressing human 
EWSR1-ERG, crosses were made between the TG(14xUAS:GFP-
 and 
driven GFP-EWSR1-ERG gene and the Gal4 gene have EWSR1-ERG 
 Deyolking and protein isolation was performed on 20 embryos 
were prepared for LC-MS/MS, which is also described in higher detail in 
with DTT and digestion of the protein with trypsin took place in the pieces 






the WTcontrol and EWS-ERG were calculated for both sets of samples, 
and 1245 consistently upregulated and 369 consistently downregulated 
 Calculating P-values to determine if the observed fold changes 
8
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 3dpf embryos 
resultant from a cross between the and 
A wildtype 
Schematic overview of sample preparation for LC-
 For each sample, 20 3dpf embryos were deyolked in using deyolking 




the correlation of read-percentages for replicates of the  wildtype control 
2 2
Scatterplot illustrating the correlation of the fold changes between biological 
are also a number of proteins with small fold changes in Q2 and Q4, where 
EWS-ERG samples of both replicates compared to the control group with an 
8
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suggested by Park et al. to perform a label swap for such experiments, 
20 Protein fold changes can then be plotted 
graph was generated based on fold changes between EWS-ERG and 
indicated with black dots, whereas the remaining proteins are indicated 
 
 Further investigation into the up- and down regulated proteins 
was done by analyzing their enrichment in various pathways and 
biological processes using the Database for Annotation, Visualization 
17,18 For this purpose, the 
ID of their human homologs, as DAVID is most suited for this type of 
19
processes, and pathways for both the up- and downregulated genes, as 
 In the upregulated gene set, various processes and pathways 
The highest number of genes could be grouped under the GO term 
Necdin has been shown in mice to increase the binding between Sirt1 and 
21 Sirt1 in turn suppresses p53-mediated apoptosis by regulating the 
22
data, protein levels of Notch2  were also found to be downregulated in 
Analysis of several EWS cell lines revealed expression of various WNTs 
23 In another study, WNT5a was shown to 




enriched terms and pathways only one or two genes relevant to the 
In vivo
 For in vivo  analysis of Notch activity, the TG(EPV.Tp1-Mmu.
ia7 
driven by a Notch-responsive box containing 12 copies of the Epstein Barr 
line was crossed with the 
s1999t
The 
ia7  line, to 
generate embryos expressing human GFP-tagged EWSR1-ERG in 
heterozygosity of the parents for 14xUAS:GFP-EWSR1-ERG, not all 
Notch homologs of maternal origin can be found in the 2-cell stage, 
and stages thereafter, Notch expression remains present in different 
25 When introducing 
neuronally targeted EWSR1-ERG, no Notch activity could be observed 
ERG expression, regular expression patterns of Notch activity could be 
Discussion
EWSR1-ERG is the second most commonly occurring translocation in 
translocation occurs between EWSR1 and FLI1, and there have been 
many investigations in the effect of knockdown or exogenous expression 





and processes, such as oncogenesis, transcription and translation, and 
 Several WNT proteins and Frizzled proteins have been shown 
23 The Wnt/Frizzled 
26 
24 Although CXCR4 was not found 
regulation of cxcr4 and its ligand cxcl12
In vivo Two representative  2 dpf embryos 
resultant from a cross between the  and 
, ia7 
while there is an absence of Notch reporter activity in these embryos, as 
A wild-type sibling 




Necdin has been shown to be involved in the neuronal development, by 
21 It suppresses apoptosis by 
causes an increase in deacetylation of p53 by Sirt1, which leads to its 
22 In EWS 
to be downregulated, and notch signalling overall was lost in these 
in vivo
results strengthen the case for investigating reactivation of the notch 
in vivo 
downregulation of notch signalling, were comparable to other EWS 
into the effect of EWSR1-ERG in vivo
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metastases are present, the outlook of patients diminishes greatly: from 
an event-free survival rate of 60-70% in the case of localised disease, 
suppressor genes and oncogenes, which supports the translational 
weeks post-fertilisation, there is no mature adaptive immune system, 
permitting the engraftment of human cancer cells without additional 
), where EWS cells are implanted to the yolk of 2-day-old 
a rapid method of looking at the proliferation and migration properties 
of cancer cells in vivo, and the changes of these behaviours upon 
model is its supreme aptness for doing non-invasive live in vivo 
used for time-lapse microscopy by embedding them in low melt-point 
is available, aiding in the investigation of interactions of tumour cells 
with the vasculature, the immune system, and other components of the 
ia7 ) allow monitoring of 
morpholino technology, which can produce transient gene knockdown 
yolk, migration away from the site of injection can be observed, and also 
we have not followed the development of cells that have settled at these 
9
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Although regulatory permission to investigate tumour formation in the 
then will come into play, such as the need for immunosuppression once 
is relatively high for the embryos, especially at the site of injection, 
presented 2-day-old engraftment model will be for rapid investigation of 
 As is demonstrated in , many efforts are ongoing to 
have done with this goal in mind in , and show the dynamics 
of EWS cell behaviour after robotic implantation into blastula-staged 
at this stage of development are more fragile, and cannot withstand 
the expression of EWS marker CD99, further characterization of these 
cells would be interesting to see how they are affected by the embryonic 
would be that there are simply too little amount of cells to achieve 
thought, perhaps this subset of cells is stimulated by other cells in the 
blastula model has three to four times less cells implanted than in the 
manual model, it could be that no cells are triggered to move from their 
in Chapter 6 that the effect of drugs in vitro does not always comply with 
the same conditions in vivo
combinations concurred between the two experiments, EW7 failed to 
able to inhibit proliferation of this cell line in vivo
developed drugs do not make it from the bench to the clinic, partially due 
in vivo
from the testing pipeline as early as possible, to avoid investing time 
of compounds in an in vivo setting, while at the same time, being a 
9
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engraftment models presented in Chapter 2 and Chapter 3 may be 
 In addition to the xenograft model, this thesis also describes 
of origin for EWS is unknown, making transgenic animal models for 
aberration in EWS, an EWSR1-ETS translocation gene, is highly 
toxic when introduced in cells, and caused embryonic lethality when 
EWSR1-FLI1 
malignant peripheral nerve sheet tumours arisen from the p53-mutated 
presenting with SRBCTs is due to the cellular context in which EWSR1-
EWSR1-FLI1 and EWSR1-ERG 
under control of a UAS promotor, expression only takes place when a 
GAL4 driver lines, EWSR1-ETS expression can be targeted to various 
were not able to generate the EWSR1-FLI1 transgenic line, to represent 
leakiness of the promoter: if there is inadvertent expression of EWSR1-
the case of the EWSR1-ERG transgenic line, out of circa 150 injected 
expected percentage of founders when using the Tol2 transposase 
the EWSR1-ERG founder we did identify, we could investigate which 
EWSR1-ERG was shown to have pronounced effects on embryonic 
embryos, whereas it was lost in embryos were expression was targeted 
that there was an overlap of genes expressed in these embryos and a 
models, suggesting that the expression of the human driver of EWS 
investigation with this model by combination with other GAL4 driver lines 
should yield interesting insights into the mechanisms of the EWSR1-
9
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 Additional characterization of the transgenic model was done 
by a proteomic analysis of embryos neuronally expressing EWSR1-
was interesting because upregulation of Necdin in a murine model was 
shown to increase the binding between Sirt1 and p53, as a mechanism 
, SIRT1 was 
using signalling reporter lines, the downregulation of Notch signalling in 
in vivo
 In conclusion, in this thesis three novel in vivo models for EWS 
embryos and the high-throughput xenograft model into blastula-staged 
provide a more fundamental understanding of the effects of exogenous 





bot- en weke delen sarcoom wat kinderen en jongvolwassenen aangrijpt, 
en een kwart van patiënten presenteert met metastasen op het moment 
van de patiënt slecht: waar er met lokale ziekte een 60-70% kans van 
overleven zonder terugval is, neemt dit af naar slechts 20-30% in het 
naar voren gebracht als een innovatief model organisme voor EWS 
van conservatie van tumor suppressie genen en oncogenen tussen 
mens en zebravis, wat de translationele waarde van transgene zebravis 
de scheiding in tijd tussen ontwikkeling van het aangeboren en adaptief 
na fertilisatie is er geen volledig ontwikkeld adaptief immuunsysteem, 
wat toelaat humane kanker cellen te implanteren zonder additionele 
), waarbij EWS cellen worden geïmplanteerd in de dooier 
van 2 dagen oude zebravis embryo’s, is een nuttige nieuwe techniek in 
naar deling en migratie van kanker cellen in vivo, en de veranderingen 
van deze eigenschappen wanneer behandeling met chemische stoffen 
van dit model is diens buitengewone bekwaamheid voor het uitvoeren 
van niet-invasieve, live microscopie in vivo.
toegepast in dit proefschrift, kunnen zebravis embryo’s gebruikt worden 
voor het maken van timelapse-videos door ze in te bedden in agarose 
batterij aan transgene en mutante zebravis lijnen beschikbaar, wat 
uitkomst biedt bij het onderzoek naar interactie tussen tumor cellen en 
het bloedvatenstelsel, het immuunsysteem, en andere componenten 
TG(EPV.Tp1-Mmu.
ia7 vis voor de Notch signalleringsroute, gebruikt in 
) maken het mogelijk de activiteit van signaaltransductie in 
systeem is het produceren van mutante zebravislijnen en relatief snel 
morpholino technologie beschikbaar, waarmee transiënte verlaging van 
Al deze beschikbare technologieën samen maken de zebravis een zeer 
10
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Echter, geen enkele techniek is zonder haar beperkingen: dit model 
is ontworpen met vooral de eerste stadia van tumor progressie in 
van de plek van implantatie waargenomen worden, evenals proliferatie 
we de verdere ontwikkeling van cellen gevestigd op secundaire locaties 
laatste dag van het merendeel van zebravis experimenten als gevolg 
aan te vragen om de tumor ontwikkeling na dit tijdspunt in het implantatie 
Bijvoorbeeld de noodzaak van immunosuppressiva, naarmate het 
groot is voor de embryo’s, vooral op de plek van implantatie, is het goed 
aantrekkingskracht van het gepresenteerde implantatie model zijn voor 
snel onderzoek naar vroege processen in de ontwikkeling van EWS 
, zijn er veel ontwikkelingen 
gaande om het volledige potentieel van het embryonale zebravis 
model organisme te benutten voor hoge-doorvoer screenings met als 
gedaan met dit doel in ogen in , en laten de dynamiek van 
EWS cel gedrag zien na geautomatiseerde implantatie in embryo’s op 
zijn de embryo’s op blastula stadium kwetsbaarder, en tolereren geen 
groot aantal cellen, gezien dit een hogere mate van letaliteit als gevolg 
positief waren voor de EWS marker CD99, zou verdere karakterisering 
van deze cellen interessant zijn, om te zien hoe zij beïnvloed worden 
voor het gebrek aan migratie kan zijn dat er simpelweg te weinig cellen 
van de cellen kunnen migreren, wat ook geobserveerd werd in het 
deze deelverzameling van cellen mogelijk tot migratie gestimuleerd door 
keer minder cellen geïmplanteerd in de dooier heeft dan het handmatige 
injectiemodel, kan het zijn dat de cellen niet gestimuleerd worden om 
migratie, is dit model echter nog altijd nuttig voor het screenen van 
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laten we zien dat het effect van medicijnen in vitro niet altijd overeenkomt 
met dezelfde condities in vivo
geneesmiddel behandeling combinaties dezelfde resultaten gaven 
tussen de verschillende experimenten, vertoonde EW7 geen respons 
in 2 dagen oude vissen wel in staat tot het verminderen van deling van 
deze cellijn in vivo. Een groot deel van ontwikkelde geneesmiddelen 
halen het niet van werkbank naar de kliniek, deels door ontoereikende 
effecten in vivo
de pijplijn te verwijderen, zodat er zo min mogelijk tijd en geld in hun 
staat toe geneesmiddelen in vivo te testen, terwijl het tegelijk een snelle 
3 verder ontwikkeld worden voor implantatie van patiënt-afgeleide 
cellen gebruiken, wat voordelig is wanneer er weinig tumor materiaal 
 Naast het implantatie model, beschrijft dit proefschrift een nieuw 
transgeen zebravis model voor EWS in 
oorsprong onbekend is voor EWS, is het maken van een transgeen 
moleculaire afwijking, een EWSR1-ETS translocatie gen, is zeer 
toxisch wanneer geïntroduceerd in cellen, en veroorzaakt embryonale 
poging om het EWSR1-FLI1 gen in zebravis met p53 mutaties te 
introduceren, leidde tot tumor ontwikkeling in een deel van de vissen die 
perifere zenuwschedetumoren, die ontstonden als gevolg van de p53-
Mogelijk is het lage aantal vissen met SRBCTs te verklaren door de 
EWSR1-FLI1 en EWSR1-ERG 
onder controle van een UAS promotor te plaatsen, vindt expressie 
alleen plaats wanneer er ook GAL4 aanwezig is om de UAS promotor te 
dat wij niet in staat waren de EWSR1-FLI1 transgene lijn te genereren, 
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van GAL4 toch expressie is van EWSR1-ETS in vroege stadia van 
In the geval van de EWSR1-ERG transgene lijn is er, uit circa de 150 
met het nageslacht van de gevonden EWSR1-ERG founder konden we 
onderzoeken welke GAL4 lijnen geschikt waren om op expressie van 
EWSR1-ERG werd door deze embryo’s in stand gehouden, waar het 
verloren ging in embryo’s die het gen in andere weefsels tot expressie 
tussen de genen tot expressie gebracht in de embryo’s met neuronale 
gereguleerde genen in EWS aan de hand van andere modellen voor de 
aanstuurt, in zebravis embryonale cellen een gedeeltelijke transformatie 
een veelbelovend uitgangspunt, en verder onderzoek met dit model in 
combinatie met andere GAL4 lijnen zou interessante inzichten in de 
mechanismes van werking van het EWSR1-ERG oncogen op kunnen 
 Verdere karakterisatie van het transgene model is gedaan door 
Gebruik makend van LC-MS/MS met spectral counting, konden wij 
studies in een muismodel de inductie van Necdin binding tussen Sirt1 en 
p53 stimuleerde, als mechanisme op post-mitotische neuronale apoptose 
van vislijnen die signallering activiteit aan kunnen tonen middels aan- 
Notch signalering activiteit in de embryo’s bevestigd worden in vivo
in vivo modellen 
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model in twee-dagen-oude embryo’s en het geautomatiseerde model 
in blastula-stadium embryo’s voor hoge-doorvoer doeleinden bieden 
een meer fundamenteel inzicht bieden in het effect van exogene 
het gemak waarmee het zebravisgenoom gemanipuleerd kan worden, 
kunnen de modellen aangepast worden naarmate verdere inzichten in 
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MCD Cumulative migration distance
MPC Mesenchymal progenitor cell
MR Mean reduction
MSC Mesenchymal stem cell
O/N Overnight
PAS Periodic acid-Schiff 





PVS Perivitelline space 
SIV Subintestinal vein
SOI Site of implantation/injection
SRBCT Small round blue cell tumours
TFA
TMA Tissue microarray
VAST Vertebrate Automated Screening Technology 
VIDE
Chemotherapeutic protocol using vincristine, ifosfamide, 
doxorubicine and etoposide 
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